Read more
12:02 PM · 18 May 2020

Moderna’s stocks surge in pre-market on vaccine hopes. Dow futures up 500 points

-
-
Open account Download free app
Moderna’s (MRNA.US)  announced that its experimental vaccine for coronavirus showed promise in early trials. Biotech company announced that it's  early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants.  Vaccine also kept the virus that causes Covid-19 from replicating in the lungs of mice. Moderna has developed the first experimental coronavirus medicine, but an approved treatment is more than a year away.
Moderna’s (MRNA.US) stock rocketed over 28% in pre market trading. Source: xStation5
S&P500 (US500) -  Futures contracts tied to the major U.S. stock indexes rose sharply Monday, as news from a Moderna trial stoked optimism about a potential coronavirus vaccine. Source: xStation5
13 February 2026, 9:05 AM

Arista Networks closes 2025 with record results!

13 February 2026, 6:54 AM

Morning Wrap: Global sell-off in the technology sector (13.02.2026)

12 February 2026, 7:03 PM

Daily summary: Silver plunges 9% 🚨Indices, crypto and precious metals under pressure

12 February 2026, 5:01 PM

US100 loses 1.5% 📉

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits